Zyprexa Im 10.0 mg Powder for solution for injection
PDF Leaflet Revision Date: 1 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Control of agitation in schizophrenia and acute mania.
Dosage (summary)
10 mg IM, may repeat up to 30 mg/day; elderly: 2.5-5 mg.
Onset of Action / Duration
Onset: 15-45 mins, Duration: not specified
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not established; monitor newborns for withdrawal symptoms.
Key Drug Interactions
- Benzodiazepines
- CYP1A2 inhibitors
- Antihypertensives
Contraindications
- Hypersensitivity to olanzapine
- Narrow-angle glaucoma
Common side effects
- Somnolence
- Bradycardia
- Hypotension
Counselling Points
- Avoid alcohol
- Monitor for sedation
- Report any unusual symptoms
Serious warnings
- Risk of NMS
- Cerebrovascular events in elderly
- Discontinuation reactions
Important Disclaimer
The Zyprexa Im 10.0 mg Powder for solution for injection professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
